Literature DB >> 2220671

The frequency of uterine leiomyomas.

S F Cramer1, A Patel.   

Abstract

As a leading cause of hysterectomy in premenopausal women. uterine leiomyomas are a major public health problem. However, very little work has been done on their epidemiology. Indeed, their true frequency has never been established using systematic and meticulous methods. In this study, gross serial sectioning at 2-mm intervals was applied as an adjunct to routine pathology processing in 100 consecutive total hysterectomy specimens. This tripled the number of leiomyomas noted in routine pathology reports. There were 649 leiomyomas in 77 of 100 uteri, with multiplicity of leiomyomas in 84%. Although leiomyomas were more numerous and larger in women with a clinical diagnosis of myomatous uterus, the incidence was no higher than in uteri removed for other reasons. The postmenopausal incidence of leiomyomas was no lower than the premenopausal incidence, although postmenopausal leiomyomas were smaller and fewer. These findings suggest that epidemiologic studies of leiomyomas may not be valid if they are based only on clinical diagnoses or routine pathology reports.

Entities:  

Mesh:

Year:  1990        PMID: 2220671     DOI: 10.1093/ajcp/94.4.435

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  196 in total

1.  Disseminated peritoneal leiomyomatosis after laparoscopic supracervical hysterectomy with characteristic molecular cytogenetic findings of uterine leiomyoma.

Authors:  Zehra Ordulu; Paola Dal Cin; Wilson W S Chong; Kwong Wai Choy; Charles Lee; Michael G Muto; Bradley J Quade; Cynthia C Morton
Journal:  Genes Chromosomes Cancer       Date:  2010-12       Impact factor: 5.006

2.  Different characteristics of mitochondrial microsatellite instability between uterine leiomyomas and leiomyosarcomas.

Authors:  Jae-Ho Lee; Tae-Yung Ryu; Chi-Heum Cho; Dae-Kwang Kim
Journal:  Pathol Oncol Res       Date:  2010-09-18       Impact factor: 3.201

3.  Comparison between diffusion-weighted imaging, T2-weighted, and postcontrast T1-weighted imaging after MR-guided, high intensity, focused ultrasound treatment of uterine leiomyomata: preliminary results.

Authors:  Michael A Jacobs; David H Gultekin; Hyun S Kim
Journal:  Med Phys       Date:  2010-09       Impact factor: 4.071

4.  Immunoexpression of Steroid Hormone Receptors and Proliferation Markers in Uterine Leiomyoma and Normal Myometrial Tissues from the Miniature Pig, Sus scrofa.

Authors:  Kristie Mozzachio; Alicia B Moore; Grace E Kissling; Darlene Dixon
Journal:  Toxicol Pathol       Date:  2015-12-20       Impact factor: 1.902

Review 5.  Pathophysiology of heavy menstrual bleeding.

Authors:  Dharani K Hapangama; Judith N Bulmer
Journal:  Womens Health (Lond)       Date:  2015-12-23

6.  Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer.

Authors:  Laveta Stewart; Gladys M Glenn; Pamela Stratton; Alisa M Goldstein; Maria J Merino; Margaret A Tucker; W Marston Linehan; Jorge R Toro
Journal:  Arch Dermatol       Date:  2008-12

7.  Enhancing uterine fibroid research through utilization of biorepositories linked to electronic medical record data.

Authors:  Lani Feingold-Link; Todd L Edwards; Sarah Jones; Katherine E Hartmann; Digna R Velez Edwards
Journal:  J Womens Health (Larchmt)       Date:  2014-12       Impact factor: 2.681

Review 8.  Leiomyomata uteri: hormonal and molecular determinants of growth.

Authors:  Richard Enrique Blake
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

9.  Expression of p53 and p21(WAF-1), apoptosis, and proliferation of smooth muscle cells in normal myometrium during the menstrual cycle: implication of DNA damage and repair for leiomyoma development.

Authors:  Ayako Suzuki; Masatoshi Kariya; Noriomi Matsumura; Tsukasa Baba; Haruhiko Yagi; Masaki Mandai; Ikuo Konishi; Shingo Fujii
Journal:  Med Mol Morphol       Date:  2012-12-07       Impact factor: 2.309

10.  Evaluating risk factors for differences in fibroid size and number using a large electronic health record population.

Authors:  Michael J Bray; Eric S Torstenson; Sarah H Jones; Todd L Edwards; Digna R Velez Edwards
Journal:  Maturitas       Date:  2018-05-11       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.